1. Introduction to Pharmaceutical Licensing In the fast-paced world of pharmaceuticals, innovation is the lifeblood that keeps the industry pumping. […]
Source
Licensing Agreements in the Pharmaceutical Sector: A Comprehensive Guide Read Post »
OPANA ER (oxymorphone hydrochloride) Endo pharms Patent: 8,114,383 Expiration: Aug 8, 2024 See More … For more information on how […]
Source
Drug Patent Expirations for the Week of August 4, 2024 Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Bulgaria? Read Post »
Recent Changes in Biosimilar Patent Law: A Shift Towards Greater Uptake and Simplification The biosimilar industry has witnessed significant changes
In the rapidly evolving landscape of pharmaceutical research and development, artificial intelligence (AI) has emerged as a game-changing tool. While […]
Source
Excipients play a crucial role in the development and formulation of pharmaceutical products. These substances, often overlooked as inert additives, can significantly influence the efficacy of a drug by altering its solubility, dissolution rate, and bi…
Blockchain technology is revolutionizing various industries, and the pharmaceutical sector is no exception. With its decentralized, transparent, and tamper-proof nature, […]
Source
Real World Blockchain Uses in the Pharmaceutical Industry Read Post »
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]
Source
How Premarin Maintained Market Dominance Without Patent Protection Read Post »
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It […]
Source
Get new actionable insights and updates from BiotechBlog
